Aussie radiopharmaceutical company AdvanCell collects $112 million in Series C financing

SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis led the round.

3 February 2025•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.